Table 2.
Treatment duration, adherence, and cure in patients newly diagnosed with leprosy registered in the 100 Million Brazilian Cohort from 2007 to 2014, according to operational disease classification
| Total | Paucibacillary | Multibacillary | ||
|---|---|---|---|---|
| Overall population | ||||
| Patients, n | 11 456 | 5140 | 6316 | |
| Months between diagnosis and end of treatment | 10·1 (5·9–12·4) | 6·1 (5·5–7·4) | 11·8 (10·8–13·3) | |
| Treatment adherence* | ||||
| No | 1948 (17·0%) | 648 (12·6%) | 1300 (20·6%) | |
| Yes | 9508 (83·0%) | 4492 (87·4%) | 5016 (79·4%) | |
| Cure | ||||
| No (death, transfer of health unit, default) | 1379 (12·0%) | 459 (8·9%) | 920 (14·6%) | |
| Yes | 10 077 (88·0%) | 4681 (91·1%) | 5396 (85·4%) | |
| Children younger than 15 years | ||||
| Patients, n | 1726 | 1089 | 637 | |
| Months between diagnosis and end of treatment | 7·0 (5·7–11·7) | 6·1 (5·4–7·1) | 12·1 (10·9–13·6) | |
| Treatment adherence* | ||||
| No | 226 (13·1%) | 125 (11·5%) | 101 (15·9%) | |
| Yes | 1500 (86·9%) | 964 (88·5%) | 536 (84·1%) | |
| Cure | ||||
| No (death, transfer of health unit, default) | 169 (9·8%) | 94 (8·6%) | 75 (11·8%) | |
| Yes | 1557 (90·2%) | 995 (91·4%) | 562 (88·2%) | |
Data are n, n (%), or median (IQR).
*
Completing the minimum number of doses (at least six for paucibacillary cases and at least 12 for multibacillary cases).